The high cost of drugs due to heavy import reliance has triggered a growing demand for increased local manufacturing of specialised drugs tailored to the unique genetic needs of Nigerians.
Key stakeholders within the Health Federation of Nigeria (HFN) are seeking government support to transition
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
